Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

GlaxoSmithKline, the mid-cap pharma company, for FY 2022, the company has recommended a final dividend and also fixed the record date for the same

This Pharma Company Fixes Record Date For Dividend At Rs 150/ Equity Share; Know Details

GlaxoSmithKline Pharmaceuticals Ltd is a large-cap pharmaceutical company with a market capitalization of ₹25,764 crore.

This large cap pharma stock fixes record date for ₹150 dividend

In a series of decisions on Tuesday, the Competition Commission of India (CCI) has given its approvals to the BC Asia Investments X-IIFL Wealth Management deal, Viatris-Biocon Biologics deal and to the acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings Ltd

CCI Clears BC Asia-IIFL, Viatris-Biocon Biologics Deals, Acquisition of GSK Restructuring

Glaxosmithkline Pharmaceuticals Ltd witnessed volume of 70382 shares by 10:45 IST on BSE, a 35.92 times surge over two-week average daily volume of 1959 shares

Volumes jump at Glaxosmithkline Pharmaceuticals Ltd counter

Adani Power, GlaxoSmithKline Pharmaceuticals, and more figure on this list of high-growth companies.

These BSE 500 firms posted up to 35,281% YoY rise in Q4 net profit; should you buy?

Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 1570 in its research report dated May 16, 2022.

Neutral GSK Pharma; target of Rs 1570: Motilal Oswal

Glaxosmithkline Pharmaceuticals reported a consolidated net profit of Rs 1,219.05 crore in Q4 FY22 as against a net profit of Rs 14.33 crore in Q4 FY21.

GSK Pharma records PAT of Rs 1,219 crore in Q4 FY22

Stocks to Watch Today: At 7:30 am, the SGX Nifty futures were quoting at 15,890 levels, hinting at an opening gain of 40-50 odd points for the Nifty.

Stocks to Watch: LIC, IndiGo, GSK Pharma, Max Health, PSUs, Bharat Forge

Stocks to watch today: Shares of firms like LIC, GlaxoSmithKline, InterGlobe Aviation, and others will be in focus in Tuesday’s trade

Stocks to Watch Today: Bharti Airtel, LIC, GlaxoSmithKline, InterGlobe Aviation, and Others

Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said in a regulatory filing

GlaxoSmithKline Pharma reports consolidated net loss of Rs 55 crore

GlaxoSmithKline Consolidated March 2022 Net Sales at Rs 809.63 crore, down 0.51% Y-o-Y

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.

GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

This Pharma Company Fixes Record Date For Dividend At Rs 150/ Equity Share; Know Details

This large cap pharma stock fixes record date for ₹150 dividend

CCI Clears BC Asia-IIFL, Viatris-Biocon Biologics Deals, Acquisition of GSK Restructuring

Volumes jump at Glaxosmithkline Pharmaceuticals Ltd counter

These BSE 500 firms posted up to 35,281% YoY rise in Q4 net profit; should you buy?

Neutral GSK Pharma; target of Rs 1570: Motilal Oswal

GSK Pharma records PAT of Rs 1,219 crore in Q4 FY22

GlaxoSmithKline Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

This Pharma Company Fixes Record Date For Dividend At Rs 150/ Equity Share; Know Details

This large cap pharma stock fixes record date for ₹150 dividend

CCI Clears BC Asia-IIFL, Viatris-Biocon Biologics Deals, Acquisition of GSK Restructuring

Volumes jump at Glaxosmithkline Pharmaceuticals Ltd counter

These BSE 500 firms posted up to 35,281% YoY rise in Q4 net profit; should you buy?

Neutral GSK Pharma; target of Rs 1570: Motilal Oswal

GSK Pharma records PAT of Rs 1,219 crore in Q4 FY22

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock